Neurokinin receptor antagonists

被引:28
作者
Leroy, V [1 ]
Mauser, P [1 ]
Gao, ZL [1 ]
Peet, NP [1 ]
机构
[1] Aventis Pharmaceuts, Bridgewater, NJ 08807 USA
关键词
asthma; depression; emesis; migraine; neurokinin; neurokinin receptor antagonist; substance P;
D O I
10.1517/13543784.9.4.735
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Studies on tachykinin peptides and the corresponding neurokinin receptors (NKr) have increased dramatically recently due to the discovery of selective, orally-active, metabolically stable and sometimes CNS penetrating NKr antagonists. After demonstrating the potential use for NKr antagonists in animal models, some compounds have recently progressed into clinical trials and a few results have been published. NKr antagonists have demonstrated efficacy for the treatment of emesis and depression, while results in other areas have been disappointing. Nonetheless, this area is coming to the exciting time of proof of concept in humans. Demonstration of the: involvement of tachykinin peptides in biological functions continues to grow, as do the potential indications for NKr antagonists. More drug candidates are undergoing clinical trials for various conditions and these results could widen the potential use for NKr antagonists.
引用
收藏
页码:735 / 746
页数:12
相关论文
共 68 条
  • [11] Effect of MEN 11467, a new tachykinin NK1 receptor antagonist, in acute rectocolitis induced by acetic acid in guinea-pigs
    Cutrufo, C
    Evangelista, S
    Cirillo, R
    Ciucci, A
    Conte, B
    Lopez, G
    Manzini, S
    Maggi, CA
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 374 (02) : 277 - 283
  • [12] Altered nociception, analgesia and aggression in mice lacking the receptor for substance P
    De Felipe, C
    Herrero, JF
    O'Brien, JA
    Palmer, JA
    Doyle, CA
    Smith, AJH
    Laird, JMA
    Belmonte, C
    Cervero, F
    Hunt, SP
    [J]. NATURE, 1998, 392 (6674) : 394 - 397
  • [13] Nerve growth factor induces a neurokinin-1 receptor-mediated airway hyperresponsiveness in guinea pigs
    de Vries, A
    Dessing, MC
    Engels, F
    Henricks, PAJ
    Nijkamp, FP
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (05) : 1541 - 1544
  • [14] DISCOVERY OF A POTENT SUBSTANCE-P ANTAGONIST - RECOGNITION OF THE KEY MOLECULAR DETERMINANT
    DESAI, MC
    LEFKOWITZ, SL
    THADEIO, PF
    LONGO, KP
    SNIDER, RM
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (26) : 4911 - 4913
  • [15] Antiemetic activity of the NK1 receptor antagonist GR205171 in the treatment of established postoperative nausea and vomiting after major gynaecological surgery
    Diemunsch, P
    Schoeffler, P
    Bryssine, B
    Cheli-Muller, LE
    Lees, J
    McQuade, BA
    Spraggs, CF
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 1999, 82 (02) : 274 - 276
  • [16] Dionne RA, 1996, CLIN PHARMACOL THER, V59, pOIII1
  • [17] Conserved polar residues in the transmembrane domain of the human tachykinin NK2 receptor:: functional roles and structural implications
    Donnelly, D
    Maudsley, S
    Gent, JP
    Moser, RN
    Hurrell, CR
    Findlay, JBC
    [J]. BIOCHEMICAL JOURNAL, 1999, 339 : 55 - 61
  • [18] SR-142801, THE FIRST POTENT NONPEPTIDE ANTAGONIST OF THE TACHYKININ NK3 RECEPTOR
    EMONDSALT, X
    BICHON, D
    DUCOUX, JP
    HEAULME, M
    MILOUX, B
    PONCELET, M
    PROIETTO, V
    VANBROECK, D
    VILAIN, P
    NELIAT, G
    SOUBRIE, P
    LEFUR, G
    BRELIERE, JC
    [J]. LIFE SCIENCES, 1994, 56 (01) : PL27 - PL32
  • [19] A POTENT AND SELECTIVE NONPEPTIDE ANTAGONIST OF THE NEUROKININ-A (NK2) RECEPTOR
    EMONDSALT, X
    VILAIN, P
    GOULAOUIC, P
    PROIETTO, V
    VANBROECK, D
    ADVENIER, C
    NALINE, E
    NELIAT, G
    LEFUR, G
    BRELIERE, JC
    [J]. LIFE SCIENCES, 1992, 50 (15) : PL101 - PL106
  • [20] EFFECT OF AN NK1 RECEPTOR ANTAGONIST (CP-99,994) ON HYPERTONIC SALINE-INDUCED BRONCHOCONSTRICTION AND COUGH IN MALE ASTHMATIC SUBJECTS
    FAHY, JV
    WONG, HH
    GEPPETTI, P
    REIS, JM
    HARRIS, SC
    MACLEAN, DB
    NADEL, JA
    BOUSHEY, HA
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (03) : 879 - 884